Overview

Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease

Status:
Withdrawn

Trial end date:
2007-10-01

Target enrollment:

Participant gender:

Summary

This is an open-label cross-over randomized control study comparing the effect of modafinil and methylphenidate in patients with Parkinson's disease with excessive daytime sleepiness.

Phase:

N/A

Details

Lead Sponsor:

US Department of Veterans Affairs
VA Office of Research and Development

Treatments:

Armodafinil
Methylphenidate
Modafinil